BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30720470)

  • 1. Advances in Diagnostic Immunohistochemistry for Primary Tumors of the Central Nervous System.
    Meredith DM
    Adv Anat Pathol; 2020 May; 27(3):206-219. PubMed ID: 30720470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonal Tumors of the Central Nervous System: An Update.
    Blessing MM; Alexandrescu S
    Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
    Wood MD; Halfpenny AM; Moore SR
    Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathology of tumors of the central nervous system.
    Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
    Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
    Komori T
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.
    Shih RY; Koeller KK
    Radiographics; 2018; 38(2):525-541. PubMed ID: 29528832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
    Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
    Cole BL; Pierson CR
    Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
    Cotter JA; Judkins AR
    Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.
    Murdock T; Orr B; Allen S; Ibrahim J; Sharma R; Ronnett BM; Rodriguez FJ
    Am J Surg Pathol; 2018 Nov; 42(11):1429-1444. PubMed ID: 30074494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors.
    Takei H; Bhattacharjee MB; Rivera A; Dancer Y; Powell SZ
    Arch Pathol Lab Med; 2007 Feb; 131(2):234-41. PubMed ID: 17284108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).
    Rao S; Rajeswarie RT; Chickabasaviah Yasha T; Nandeesh BN; Arivazhagan A; Santosh V
    Childs Nerv Syst; 2017 Nov; 33(11):1953-1959. PubMed ID: 28744687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential diagnosis of central nervous system tumors: a critical examination of some recent immunohistochemical applications.
    Edgar MA; Rosenblum MK
    Arch Pathol Lab Med; 2008 Mar; 132(3):500-9. PubMed ID: 18318590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics.
    Velázquez Vega JE; Brat DJ
    Adv Anat Pathol; 2018 May; 25(3):143-171. PubMed ID: 29521646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.
    Behling F; Barrantes-Freer A; Skardelly M; Nieser M; Christians A; Stockhammer F; Rohde V; Tatagiba M; Hartmann C; Stadelmann C; Schittenhelm J
    Diagn Pathol; 2016 Jun; 11(1):55. PubMed ID: 27350555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Simplified Overview of World Health Organization Classification Update of Central Nervous System Tumors 2016.
    Gupta A; Dwivedi T
    J Neurosci Rural Pract; 2017; 8(4):629-641. PubMed ID: 29204027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of recently described genetic alterations in central nervous system tumors.
    Lucas CG; Solomon DA; Perry A
    Hum Pathol; 2020 Feb; 96():56-66. PubMed ID: 31678207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology.
    Judkins AR
    Adv Anat Pathol; 2007 Sep; 14(5):335-9. PubMed ID: 17717433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical teratoid/rhabdoid tumors with multilayered rosettes in the pineal region.
    Wang J; Liu Z; Fang J; Du J; Cui Y; Xu L; Li G
    Brain Tumor Pathol; 2016 Oct; 33(4):261-266. PubMed ID: 27307151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
    Miller DC
    Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.